Long-Term Efficacy of Dapagliflozin as Add-On to Metformin (MET) in T2DM Inadequately Controlled with MET Alone

被引：0
|
作者：
Bailey, Clifford J.
Gross, Jorge L.
Yadav, Manoj
Iqbal, Nayyar
Mansfield, Traci A.
List, James F.
机构：
来源：
DIABETES | 2011年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
988-P
引用
收藏
页码：A271 / A271
页数：1
相关论文
共 50 条
  • [41] The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy
    Fouqueray, Pascale
    Pirags, Valdis
    Inzucchi, Silvio E.
    Bailey, Clifford J.
    Schernthaner, Guntram
    Diamant, Michaela
    Lebovitz, Harold E.
    DIABETES CARE, 2013, 36 (03) : 565 - 568
  • [42] Efficacy and Safety of Gemigliptin as Add-on Therapy in Patients with Type 2 Diabetes Inadequately Controlled on Metformin and Glimepiride
    Han, Kyung Ah
    Yu, Jae Myung
    Jang, Hak Chul
    Ahn, Kyu Jeung
    Oh, Takkeun
    Lee, Hyoung Woo
    Lee, Daeho
    Kim, Jae Taek
    Park, Tae Sun
    Nam, Joo Young
    Chung, Choon Hee
    Kim, Byung-Joon
    Park, Seok Won
    Kim, Sung-Ho
    Park, Kyong Soo
    DIABETES, 2016, 65 : A307 - A307
  • [43] Efficacy and safety of gemigliptin as add-on therapy in patients with type 2 diabetes inadequately controlled on metformin and glimepiride
    Kim, S. -H.
    Yu, J.
    Jang, H.
    Song, Y.
    Ahn, K.
    Oh, T.
    Lee, H.
    Lee, D.
    Kim, J.
    Park, T. -S.
    Jeong, C. -H.
    Kim, B. -J.
    Han, K.
    Park, K.
    DIABETOLOGIA, 2016, 59 : S357 - S357
  • [44] Efficacy and safety of gemigliptin as add-on therapy in patients with type 2 diabetes inadequately controlled on metformin and glimepiride
    Han, Kyung Ah
    Yu, Jae Myung
    Jang, Hak Chul
    Song, Young Duk
    Ahn, Kyu Jeung
    Oh, Takkeun
    Lee, Hyoung Woo
    Lee, Daeho
    Kim, Jae Taek
    Jeong, Choon-hee
    Kim, Byoung-joon
    Park, Kyong Soo
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S125 - S126
  • [45] Target Achievement and Quality Measure (QM) Attainment with Titrated Canagliflozin (CANA) in Patients with Type 2 Diabetes Mellitus (T2DM) as Add-on to Metformin (MET) plus Sitagliptin (SITA)
    Seufert, Jochen
    Aggarwal, Naresh
    Bailey, Robert
    Cao, Anjun
    Fung, Albert
    Pfeifer, Michael
    Alba, Maria
    Rodbard, Helena W.
    DIABETES, 2016, 65 : A308 - A308
  • [46] Durability of glycaemic efficacy over 2 years with dapagliflozin versus glipizide as add-on therapies in patients whose type 2 diabetes mellitus is inadequately controlled with metformin
    Nauck, M. A.
    Del Prato, S.
    Duran-Garcia, S.
    Rohwedder, K.
    Langkilde, A. M.
    Sugg, J.
    Parikh, S. J.
    DIABETES OBESITY & METABOLISM, 2014, 16 (11): : 1111 - 1120
  • [47] Dapagliflozin as Add-On Therapy in Asian Patients with Type 2 Diabetes Inadequately Controlled on Insulin
    Yang, Wenying
    Ma, Jianhua
    Li, Yiming
    Li, Yanbing
    Zhou, Zhiguang
    Kim, Jae Hyeon
    Zhao, June
    Ptaszynska, Agata
    DIABETES, 2017, 66 : A338 - A338
  • [48] Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
    Clifford J Bailey
    Jorge L Gross
    Delphine Hennicken
    Nayyar Iqbal
    Traci A Mansfield
    James F List
    BMC Medicine, 11
  • [49] Efficacy and safety of vildagliptin, sitagliptin, and linagliptin as add-on therapy in Chinese patients with T2DM inadequately controlled with dual combination of insulin and traditional oral hypoglycemic agent
    Yun-Zhao Tang
    Gang Wang
    Zhen-Huan Jiang
    Tian-Tian Yan
    Yi-Jun Chen
    Min Yang
    Ling-Ling Meng
    Yan-Juan Zhu
    Chen-Guang Li
    Zhu Li
    Ping Yu
    Chang-Lin Ni
    Diabetology & Metabolic Syndrome, 7
  • [50] Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
    Bailey, Clifford J.
    Gross, Jorge L.
    Hennicken, Delphine
    Iqbal, Nayyar
    Mansfield, Traci A.
    List, James F.
    BMC MEDICINE, 2013, 11
12345